Nisa Investment Advisors LLC Trims Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Nisa Investment Advisors LLC reduced its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 75,911 shares of the company’s stock after selling 438 shares during the quarter. Nisa Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $5,935,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Sky Investment Group LLC increased its stake in GE HealthCare Technologies by 0.5% in the 4th quarter. Sky Investment Group LLC now owns 50,955 shares of the company’s stock valued at $3,984,000 after buying an additional 248 shares during the period. BigSur Wealth Management LLC boosted its holdings in shares of GE HealthCare Technologies by 51.7% in the fourth quarter. BigSur Wealth Management LLC now owns 4,000 shares of the company’s stock valued at $313,000 after acquiring an additional 1,364 shares in the last quarter. Bremer Bank National Association acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth about $4,990,000. Community Bank of Raymore raised its holdings in GE HealthCare Technologies by 18.3% during the fourth quarter. Community Bank of Raymore now owns 14,813 shares of the company’s stock worth $1,158,000 after purchasing an additional 2,296 shares in the last quarter. Finally, Hall Laurie J Trustee lifted its position in GE HealthCare Technologies by 13.5% in the fourth quarter. Hall Laurie J Trustee now owns 2,742 shares of the company’s stock valued at $214,000 after purchasing an additional 327 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the topic of several recent analyst reports. Evercore ISI boosted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Stifel Nicolaus increased their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Trading Up 0.6 %

Shares of GE HealthCare Technologies stock opened at $88.67 on Friday. GE HealthCare Technologies Inc. has a 1 year low of $71.42 and a 1 year high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The business has a 50 day moving average price of $82.32 and a 200 day moving average price of $84.69. The company has a market capitalization of $40.51 billion, a P/E ratio of 24.36, a P/E/G ratio of 2.88 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.99 earnings per share. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.